You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 12, December 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Dermatology
 •Melanoma
 •Alert me on articles by topic

Immunophenotype of Conjunctival Melanomas

Comparisons With Uveal and Cutaneous Melanomas

Satori Iwamoto, MD, PhD; Robert C. Burrows, PhD; Hans E. Grossniklaus, MD; James Orcutt, MD, PhD; Robert E. Kalina, MD; Michael Boehm, MD; Mark A. Bothwell, PhD; Rodney Schmidt, MD, PhD

Arch Ophthalmol. 2002;120:1625-1629.

Objective  To characterize the immunophenotypic expression pattern of conjunctival melanomas, with the use of standard melanoma markers as well as microphthalmia transcription factor and p75 neurotrophin receptor.

Design  Eleven conjunctival melanomas, including 1 caruncular melanoma, were immunolabeled with a panel of antibodies that included S100, tyrosinase, melan-A, HMB-45 and HMB-50 combination, microphthalmia transcription factor, and p75 neurotrophin receptor. The results were tabulated on the basis of intensity and pervasiveness of labeling and compared with a previous study of uveal melanomas.

Results  Immunolabeling with S100 was at significantly higher levels in conjunctival melanomas than in uveal melanomas. Tyrosinase, HMB-45 and HMB-50 combination, melan-A, and microphthalmia transcription factor were expressed at high levels in conjunctival melanomas, whereas p75 neurotrophin receptor was not expressed.

Conclusions  Melanomas of the conjunctiva, including the caruncle, expressed S100, tyrosinase, melan-A, HMB-45 and HMB-50 combination, and microphthalmia transcription factor at high levels, suggesting that these are good markers for this melanoma subtype. Expression of S100 was significantly higher in conjunctival melanomas than in uveal melanomas. The immunophenotypic pattern of conjunctival melanomas is most similar to the epithelioid subtype of cutaneous melanomas.


From the Departments of Medicine (Dr Iwamoto), Physiology and Biophysics (Drs Iwamoto and Bothwell), Radiology/Imaging Research Laboratory (Dr Burrows), Ophthalmology (Drs Orcutt, Kalina, and Boehm), and Pathology/Immunocytochemistry (Dr Schmidt), University of Washington Medical Center, Seattle; and the Department of Ophthalmology, Emory University, Atlanta, Ga (Dr Grossniklaus).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BRAF Mutations in Conjunctival Melanoma
Gear et al.
IOVS 2004;45:2484-2488.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.